Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor

By Holdich Tom   Sawyer James  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2021-2025

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor

By Moore K.H.P.   Cass L.M.   Dallow N.   Hardman T.C.   Jones A.   Boyce M.   Prince W.T.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 805-811

Springer Publishing Company

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection

By Cahn Pedro  

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 129-138

Adis International

Access to resources Recommend Favorite

Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 83-88

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses

By Guo Beining   Wu Xiaojie   Zhang Yingyuan   Shi Yaoguo   Yu Jicheng   Cao Guoying   Zhang Jing  

Clinical Drug Investigation, Vol. 32, Iss. 7, 2012-07 ,pp. : 475-486

Adis International

Access to resources Recommend Favorite